The inhibitory effect of a coronavirus spike protein fragment with ACE2

Article activity feed

1. Version published to 10.1016/j.bpj.2020.08.022

   Mar 1, 2021
2. 

   ScreenIT

   Jun 9, 2020

   SciScore for 10.1101/2020.06.03.132506: (What is this?)

   Please note, not all rigor criteria are appropriate for all manuscripts.

   Table 1: Rigor

   NIH rigor criteria are not applicable to paper type.

   Table 2: Resources

   Software and Algorithms
   Sentences	Resources
   We used the GROMACS version 4.6 package for the equilibrium MD simulations and a modified GROMACS version 4.5.5 for the enhanced correlation guided simulations (39).	GROMACS suggested: (GROMACS, RRID:SCR_014565)
   We modeled the individual hexapeptide conformers using the PyMOL modeling program (40).	PyMOL suggested: (PyMOL, RRID:SCR_000305)

   ---

   Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).

   ---

   Results from LimitationRecognizer: An explicit section about the limitations of the techniques …

   SciScore for 10.1101/2020.06.03.132506: (What is this?)

   Please note, not all rigor criteria are appropriate for all manuscripts.

   Table 1: Rigor

   NIH rigor criteria are not applicable to paper type.

   Table 2: Resources

   Software and Algorithms
   Sentences	Resources
   We used the GROMACS version 4.6 package for the equilibrium MD simulations and a modified GROMACS version 4.5.5 for the enhanced correlation guided simulations (39).	GROMACS suggested: (GROMACS, RRID:SCR_014565)
   We modeled the individual hexapeptide conformers using the PyMOL modeling program (40).	PyMOL suggested: (PyMOL, RRID:SCR_000305)

   ---

   Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).

   ---

   Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.

   ---

   Results from TrialIdentifier: No clinical trial numbers were referenced.

   ---

   Results from Barzooka: We did not find any issues relating to the usage of bar graphs.

   ---

   Results from JetFighter: Please consider improving the rainbow (“jet”) colormap(s) used on pages 2 and 6. At least one figure is not accessible to readers with colorblindness and/or is not true to the data, i.e. not perceptually uniform.

   ---

   Results from rtransparent:

   • No conflict of interest statement was detected. If there are no conflicts, we encourage authors to explicit state so.
   • Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
   • No protocol registration statement was detected.

   ---

   Read the original source
3. 

   Version published to 10.1101/2020.06.03.132506v1 on bioRxiv

   Jun 4, 2020